Skip to main content
YIFAN PHARMACEUTICAL CO.,LTD logo

YIFAN PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 002019 ISIN · CNE000001K65 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,497 across all filing types
Latest filing 2023-04-07 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002019

About YIFAN PHARMACEUTICAL CO.,LTD

https://www.yifanyy.com

Yifan Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and commercialization of innovative biologics, specialty small molecules, and traditional Chinese medicine. The company maintains a diverse product portfolio, notably featuring Ryzneuta (efbemalenograstim alfa), a long-acting recombinant human granulocyte colony-stimulating factor used to treat chemotherapy-induced neutropenia. It is also recognized as a major global supplier of Vitamin B5 (D-calcium pantothenate). Operating with a global perspective, the firm manages integrated R&D and production platforms that adhere to international quality standards. Its core activities span drug discovery, clinical development, and large-scale manufacturing, with a strategic emphasis on therapeutic areas such as oncology, hematology, and dermatology.

Recent filings

Filing Released Lang Actions
关于收到药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a drug registration certificate from the national drug regulatory authority. It details the approval and registration of a pharmaceutical product, including regulatory approval information, product details, clinical trial background, and potential impact on the company. The document is an official announcement of a regulatory milestone rather than a financial report, management discussion, or other report types. It does not contain financial statements, earnings data, or meeting materials. It is a regulatory announcement about a product approval, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-04-07 Chinese
关于全资子公司通过高新技术企业认定的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (575 characters) regarding a subsidiary company receiving a High-Tech Enterprise Certificate and the related tax benefits. It does not contain financial statements or detailed financial data. It is an official company announcement about a regulatory or tax status update, not a full report or detailed financial disclosure. The document is not a report itself but an announcement of a status change affecting the company. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-30 Chinese
关于对全资子公司提供担保的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a guarantee provided by the company to its wholly-owned subsidiary. It details the guarantee contract, approval by the board and shareholders, financial data of the subsidiary, and compliance with regulatory requirements. The document is relatively short (3317 characters) and focuses on a specific financing guarantee event rather than presenting comprehensive financial statements or a full report. It does not contain quarterly or annual financial results, nor is it a transcript, presentation, or legal proceeding update. It is a regulatory announcement about a financing-related guarantee, which fits best under Capital/Financing Update (CAP).
2023-03-27 Chinese
更正公告
Regulatory Filings Classification · 95% confidence The document is a correction announcement (更正公告) issued by the company 亿帆医药股份有限公司 regarding a previously published announcement about obtaining a drug registration certificate. It corrects specific details in the earlier announcement related to product description and impact/risk disclosures. The document does not contain financial statements, management discussion, or detailed financial data. It is a regulatory announcement correcting prior disclosed information rather than a full report or financial filing. The document length is short (2263 characters) and it serves to amend a prior announcement. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and correction notice.
2023-03-26 Chinese
关于获得药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a drug registration certificate from the National Medical Products Administration. It details the approval of a pharmaceutical product, its specifications, and the impact on the company. The document is short (1293 characters) and serves as a formal notification of a regulatory approval event rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or management analysis. It is not an annual or interim report, nor a call transcript or governance document. It is a regulatory announcement about a product approval, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-03-26 Chinese
关于获得药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a drug registration certificate from the National Medical Products Administration. It details the approval of a pharmaceutical product, its specifications, and the impact on the company. The document is short (1479 characters) and serves as a formal announcement of a regulatory approval event rather than a financial report or detailed filing. There is no financial data, no mention of annual or quarterly results, no management discussion, or other report types. It is not a report publication announcement since it does not mention the release of a report but rather announces a regulatory milestone. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-22 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.